Medication info
Simpex Duo Tablet 10/10mg

Simpex Duo Tablet 10/10mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Korea United Pharm Co., Ltd.
Appearance
White to pale yellow, bilaterally convex rectangular tablet
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201601736 · Approved 2016.03.31 · Insurance code 644309050

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients taking this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients taking this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Ingredients

Manufacturer
Korea United Pharm Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication is administered in conjunction with dietary therapy to reduce total cholesterol, LDL cholesterol, ApoB protein, and triglycerides in patients with primary hypercholesterolemia, particularly in heterozygous familial and non-familial patients, as well as patients with mixed hyperlipidemia. It is used as an adjunct to other therapies (e.g., LDL apheresis) for patients with homozygous familial hypercholesterolemia or in cases where other treatments are ineffective. This medication is given to patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia, particularly when there is inadequate response to appropriate dietary and non-pharmacological treatments. Prior to administration, it is essential to identify and treat other causes of dyslipidemia (such as diabetes and hypothyroidism) if necessary, and lipid levels should be monitored periodically during treatment. This medication helps to improve the patient's blood lipid profile, thereby lowering the risk of atherosclerotic disease.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients taking this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients taking this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Precautions

This medication is used to lower cholesterol. Caution should be exercised as muscle problems may occur when taking this medication. If muscle pain or weakness occurs, inform a doctor immediately. The risk of muscle damage may increase, especially when taking high doses or in conjunction with certain other drugs. This medication may affect liver function; therefore, it should not be used in patients with liver disease or elevated liver enzymes. Women who are pregnant or breastfeeding must not use this medication, and women of childbearing potential should only take it after confirming the possibility of pregnancy. This medication may interact with specific drugs; if taking other medications, always inform your doctor or pharmacist. It is not recommended for children or patients under 10 years old, and caution is required when given to the elderly. If any unusual symptoms occur while taking this medication, consult healthcare professionals immediately, and regular blood tests to monitor liver and muscle status are advisable. There is no specific antidote for overdose; therefore, you will receive general treatment according to the symptoms. It is advisable to avoid certain foods, such as grapefruit juice, while taking this medication.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, sensory disturbances, depression, cholelithiasis, cholecystitis, skin/mucosa syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptom-associated drug reactions, erythema multiforme, myasthenia, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, oculomotor disorders, facial weakness, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorders, anxiety, sleep disorders, memory decline, forgetfulness, amnesia, memory impairment, confusion, interstitial lung disease, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, fever, chills, flushing, malaise, dyspnea, conjugated hyperbilirubinemia, liver fat changes, cirrhosis, fulminant hepatic necrosis, liver cancer, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, erectile dysfunction, ophthalmoplegia, anemia, increased aminotransferases, elevated ALP, increased ɤ-GT, elevated bilirubin levels, thyroid dysfunction, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture and should be stored in a tightly sealed container. Additionally, it is important to maintain its effectiveness by storing it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White to pale yellow, bilaterally convex rectangular tablet

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.